CHICAGO--Jeffrey H. Newhouse, MD, director of the division of abdominal imaging at Columbia University Medical Center in New York City, spoke with Health Imaging News about contrast-induced nephropathy (CIN), and its potential “exaggerated risk” with IV contrast injections, especially comapred with cardiac cath procedures, due to improper appropriate controls in many clinical trials that assessed its risk.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
